Literature DB >> 17726590

[Nausea and vomiting in the postoperative phase. Expert- and evidence-based recommendations for prophylaxis and therapy].

C C Apfel1, P Kranke, S Piper, D Rüsch, H Kerger, M Steinfath, K Stöcklein, D R Spahn, T Möllhoff, K Danner, A Biedler, M Hohenhaus, B Zwissler, O Danzeisen, H Gerber, F-J Kretz.   

Abstract

There are no consensus guidelines for the management of postoperative nausea and vomiting (PONV) in German speaking countries. This meeting was intended to develop such guidelines on which individual health care facilities can derive their specific standard operating procedures (SOPs). Anesthesiologists reviewed published literature on key topics which were subsequently discussed during two meetings. It was emphasized that recommendations were based on the best available evidence. The clinical relevance of individual risk factors should be viewed with caution since even well proven risk factors, such as the history of PONV, do not allow the identification of patients at risk for PONV with a satisfactory sensitivity or specificity. A more useful approach is the use of simplified risk scores which consider the presence of several risk factors simultaneously. Most individual antiemetic interventions for the prevention of PONV have comparable efficacy with a relative risk reduction of about 30%. This appears to be true for total intravenous anesthesia (TIVA) as well as for dexamethasone and other antiemetics; assuming a sufficiently high, adequate and equipotent dosage which should be weight-adjusted in children. As the relative risk reduction is context independent and similar between the interventions, the absolute risk reduction of prophylactic interventions is mainly dependent on the patient's individual baseline risk. Prophylaxis is thus rarely warranted in patients at low risk, generally needed in patients with a moderate risk and should include a multimodal approach in patients at high risk for PONV. Therapeutic interventions of PONV should be administered promptly using an antiemetic which has not been used before. The group suggests algorithms where prophylactic interventions are mainly dependent on the patient's risk for PONV. These algorithms should provide evidence-based guidelines allowing the development of SOPs/policies which take local circumstances into account.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726590     DOI: 10.1007/s00101-007-1210-0

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  72 in total

1.  A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures.

Authors:  J Tang; M F Watcha; P F White
Journal:  Anesth Analg       Date:  1996-08       Impact factor: 5.108

2.  Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study.

Authors:  Paul F White; Dajun Song; Joao Abrao; Kevin W Klein; Bryan Navarette
Journal:  Anesthesiology       Date:  2005-06       Impact factor: 7.892

3.  Single-dose i.v. granisetron in the prevention of postoperative nausea and vomiting.

Authors:  A J Wilson; P Diemunsch; B G Lindeque; H Scheinin; H S Helbo-Hansen; M V Kroeks; K L Kong
Journal:  Br J Anaesth       Date:  1996-04       Impact factor: 9.166

4.  Treatment of postoperative nausea and vomiting with single intravenous doses of dolasetron mesylate: a multicenter trial. Dolasetron Mesylate PONV Treatment Study Group.

Authors:  A L Kovac; P E Scuderi; T F Boerner; J E Chelly; M E Goldberg; C B Hantler; W F Hahne; R A Brown
Journal:  Anesth Analg       Date:  1997-09       Impact factor: 5.108

5.  Intravenous ondansetron in established postoperative emesis in children. S3A-381 Study Group.

Authors:  S Khalil; A Rodarte; B C Weldon; M Weinstein; Z Grunwald; B Ginsberg; R Kaye; A Otto; M Wheeler; C D Lawhorn; B A Prillaman; M Creed
Journal:  Anesthesiology       Date:  1996-08       Impact factor: 7.892

6.  A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy.

Authors:  Tong J Gan; Andrew Coop; Beverly K Philip
Journal:  Anesth Analg       Date:  2005-11       Impact factor: 5.108

Review 7.  Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting.

Authors:  A Lee; M L Done
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  Logistic regression analysis of fixed patient factors for postoperative sickness: a model for risk assessment.

Authors:  M Palazzo; R Evans
Journal:  Br J Anaesth       Date:  1993-02       Impact factor: 9.166

9.  The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review.

Authors:  Peter Kranke; Astrid M Morin; Norbert Roewer; Hinnerk Wulf; Leopold H Eberhart
Journal:  Anesth Analg       Date:  2002-07       Impact factor: 5.108

10.  Prophylaxis of postoperative nausea and vomiting with oral, long-acting dimenhydrinate in gynecologic outpatient laparoscopy.

Authors:  Kim E Turner; Joel L Parlow; Nicole D Avery; Deborah A Tod; Andrew G Day
Journal:  Anesth Analg       Date:  2004-06       Impact factor: 5.108

View more
  13 in total

1.  [Prophylaxis of postoperative nausea and vomiting in pediatric anesthesia : recommendations and implementation in clinical routine].

Authors:  C Klotz; C Philippi-Höhne
Journal:  Anaesthesist       Date:  2010-05       Impact factor: 1.041

Review 2.  Nausea and vomiting after surgery under general anesthesia: an evidence-based review concerning risk assessment, prevention, and treatment.

Authors:  Dirk Rüsch; Leopold H J Eberhart; Jan Wallenborn; Peter Kranke
Journal:  Dtsch Arztebl Int       Date:  2010-10-22       Impact factor: 5.594

3.  [Fast track in vascular surgery].

Authors:  E S Debus; P Kruska; A Ivoghli; J Castan; T Kerner
Journal:  Chirurg       Date:  2009-08       Impact factor: 0.955

4.  [Low-dose droperidol in children: rescue therapy for persistent postoperative nausea and vomiting].

Authors:  E Schroeter; A Schmitz; T Haas; M Weiss; A C Gerber
Journal:  Anaesthesist       Date:  2012-01-12       Impact factor: 1.041

5.  [Adherence to treatment guidelines for postoperative nausea and vomiting. How well does knowledge transfer result in improved clinical care?].

Authors:  M Franck; F M Radtke; A Baumeyer; P Kranke; K D Wernecke; C D Spies
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

6.  [Pediatric postoperative quality analysis : Pain and postoperative nausea and vomiting].

Authors:  I Balga; C Konrad; W Meissner
Journal:  Anaesthesist       Date:  2013-09-20       Impact factor: 1.041

7.  [Inhalational anesthetics].

Authors:  Jan Jedlicka; Philipp Groene; Julia Linhart; Elisabeth Raith; Da Vy Mu Stapha; Peter Conzen
Journal:  Anaesthesist       Date:  2021-04       Impact factor: 1.041

8.  Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems.

Authors:  Annika Reintam Blaser; Manu L N G Malbrain; Joel Starkopf; Sonja Fruhwald; Stephan M Jakob; Jan De Waele; Jan-Peter Braun; Martijn Poeze; Claudia Spies
Journal:  Intensive Care Med       Date:  2012-02-07       Impact factor: 17.440

Review 9.  Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting.

Authors:  Anna Lee; Simon K C Chan; Lawrence T Y Fan
Journal:  Cochrane Database Syst Rev       Date:  2015-11-02

10.  Small dose of propofol combined with dexamethasone for postoperative vomiting in pediatric Moyamoya disease patients: a prospective, observer-blinded, randomized controlled study.

Authors:  Jeongmin Kim; Gyu Dong Jang; Dong-Suk Kim; Kyeong Tae Min
Journal:  Korean J Anesthesiol       Date:  2013-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.